As of the latest SEC filings, BIOMARIN PHARMACEUTICAL INC (BMRN) is held by 589 institutional funds. The largest fund shareholder is Dodge & Cox Stock Fund (DODGX), holding an estimated $551,886,116.25 in market value, representing 0.48% of its portfolio.
Funds holding BIOMARIN PHARMACEUTICAL INC (BMRN)
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- BMRN
- CIK:
- 0001048477
| Fund | Type | Manager | Weight | Market Value | Shares |
Report Date
|
Filing Date
|
|---|---|---|---|---|---|---|---|
|
DODGX
Dodge & Cox Stock Fund
|
MF | Independent / Boutique | 0.48% | $551,886,116.25 | 9,769,625 | Mar 31, 2026 | Jun 1, 2026 |
|
IJH
iShares Core S&P Mid-Cap ETF
|
ETF | BlackRock / iShares | 0.34% | $359,313,683.40 | 6,360,660 | Mar 31, 2026 | May 26, 2026 |
|
VTI
VANGUARD TOTAL STOCK MARKET INDEX FUND
|
ETF | Vanguard | 0.02% | $345,767,946.30 | 6,120,870 | Mar 31, 2026 | May 28, 2026 |
|
VPMAX
VANGUARD PRIMECAP FUND
|
MF | Vanguard | 0.40% | $292,587,130.50 | 5,179,450 | Mar 31, 2026 | May 28, 2026 |
|
VHCAX
VANGUARD CAPITAL OPPORTUNITY FUND
|
MF | Vanguard | 1.17% | $288,621,250.05 | 5,109,245 | Mar 31, 2026 | May 28, 2026 |
|
NAESX
VANGUARD SMALL-CAP INDEX FUND
|
ETF | Vanguard | 0.15% | $250,500,046.86 | 4,434,414 | Mar 31, 2026 | May 28, 2026 |
|
CWIAX
Capital World Growth & Income Fund
|
MF | Independent / Boutique | 0.11% | $159,031,974.23 | 2,576,251 | Feb 28, 2026 | Apr 27, 2026 |
|
VISGX
VANGUARD SMALL-CAP GROWTH INDEX FUND
|
ETF | Vanguard | 0.36% | $140,250,039.09 | 2,482,741 | Mar 31, 2026 | May 28, 2026 |
|
VEMPX
VANGUARD EXTENDED MARKET INDEX FUND
|
ETF | Vanguard | 0.15% | $121,177,546.35 | 2,145,115 | Mar 31, 2026 | May 28, 2026 |
|
FCNTX
Fidelity Contrafund
|
MF | Fidelity | 0.06% | $100,130,897.58 | 1,772,542 | Mar 31, 2026 | May 26, 2026 |
|
MDY
SPDR S&P MidCap 400 ETF Trust
|
ETF | State Street (SPDR) | 0.34% | $81,796,446.69 | 1,447,981 | Mar 31, 2026 | Jun 1, 2026 |
|
IBB
iShares Biotechnology ETF
|
ETF | BlackRock / iShares | 0.98% | $79,782,521.70 | 1,412,330 | Mar 31, 2026 | May 28, 2026 |
|
XBI
State Street(R) SPDR(R) S&P(R) Biotech ETF
|
ETF | State Street (SPDR) | 1.07% | $79,345,910.49 | 1,404,601 | Mar 31, 2026 | May 28, 2026 |
|
FBT
First Trust NYSE Arca Biotechnology Index Fund
|
ETF | First Trust | 3.40% | $77,280,579.60 | 1,368,040 | Mar 31, 2026 | May 28, 2026 |
|
POAGX
PRIMECAP Odyssey Aggressive Growth Fund
|
MF | Independent / Boutique | 1.11% | $75,393,943.65 | 1,398,515 | Apr 30, 2026 | Jun 29, 2026 |
|
FSMAX
Fidelity Extended Market Index Fund
|
MF | Fidelity | 0.15% | $62,336,558.98 | 1,009,826 | Feb 28, 2026 | Apr 24, 2026 |
|
LSIIX
Loomis Sayles Investment Grade Bond Fund
|
MF | Independent / Boutique | 0.33% | $55,785,404.80 | 55,960,000 | Mar 31, 2026 | May 29, 2026 |
|
DODBX
Dodge & Cox Balanced Fund
|
MF | Independent / Boutique | 0.37% | $53,959,248.00 | 955,200 | Mar 31, 2026 | Jun 1, 2026 |
|
SPMD
State Street(R) SPDR(R) Portfolio S&P 400(TM) Mid Cap ETF
|
ETF | State Street (SPDR) | 0.34% | $53,013,209.97 | 938,453 | Mar 31, 2026 | May 28, 2026 |
|
POGRX
PRIMECAP Odyssey Growth Fund
|
MF | Independent / Boutique | 0.96% | $52,358,793.66 | 971,226 | Apr 30, 2026 | Jun 29, 2026 |
|
DODWX
Dodge & Cox Global Stock Fund
|
MF | Independent / Boutique | 0.36% | $42,847,665.00 | 758,500 | Mar 31, 2026 | Jun 1, 2026 |
|
IWR
iShares Russell Mid-Cap ETF
|
ETF | BlackRock / iShares | 0.09% | $40,983,833.94 | 725,506 | Mar 31, 2026 | May 28, 2026 |
|
PLFLX
Aristotle Floating Rate Income Fund
|
MF | Independent / Boutique | 1.17% | $40,799,141.75 | 40,850,000 | Mar 31, 2026 | May 27, 2026 |
|
DFSVX
U.S. SMALL CAP VALUE PORTFOLIO
|
MF | Dimensional Fund Advisors | 0.21% | $39,882,725.82 | 739,802 | Apr 30, 2026 | Jun 24, 2026 |
|
CBFAX
American Funds Global Balanced Fund
|
MF | Capital Group / American Funds | 0.12% | $39,706,979.22 | 736,542 | Apr 30, 2026 | Jun 26, 2026 |
Advertisement (320x50)